5-amino levulinic acid inhibits SARS-CoV-2 infection in vitro
Yasuteru Sakurai, Mya Myat Ngwe Tun, Yohei Kurosaki, Takaya Sakura, D.K. Inaoka, Kiyotaka Fujine, Kiyoshi Kita, Kouichi Morita, Jiro Yasuda
Topics & Concepts
Levulinic acidBioavailabilityIn vitroCoronavirus disease 2019 (COVID-19)CytotoxicityAmino acidDrugSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Cell culturePandemicVirologyPharmacologyChemistryBiochemistryBiologyMedicineInfectious disease (medical specialty)GeneticsPathologyDiseaseCatalysisSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing